Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

News

Sonnet BioTherapeutics Files 10-K

https://www.sec.gov/ix?doc=/Archives/edgar/data/0001106838/000149315221031781/form10-k.htm

byBenzinga Newsdesk

December 17, 2021

1 minute read

https://www.sec.gov/ix?doc=/Archives/edgar/data/0001106838/000149315221031781/form10-k.htm

Tenable’s Biggest Takeaway Is Doubling Its Unlevered FCF, Analyst Says

By Anusuya Lahiri

Today, 1:23 PM

Needham analyst Mike Cikos maintained Tenable Holdings, Inc (NASDAQ:TENB) with a Buy and lowered the price target from $52 to $44. He…

TENB

Citigroup Asked By SEC To Update Disclosures On Russia Exposure

By Benzinga Newsdesk

Today, 1:23 PM

-Financial Times

Guggenheim Maintains Buy on Merus, Raises Price Target to $46

By Benzinga Newsdesk

Today, 1:23 PM

Guggenheim analyst Charles Zhu maintains Merus (NASDAQ:MRUS) with a Buy and raises the price target from $44 to $46.

MRUS

Tesla Giga Shanghai Said To Remain Shut Amid COVID-19 Lockdowns

By Rachit Vats

Today, 1:23 PM

Tesla Inc’s (NASDAQ: TSLA) key manufacturing plant Giga Shanghai remained shut on Friday amid citywide lockdowns in China due to a recent spike in COVID-19 cases, Nikkei Asia

TSLA

Sonnet BioTherapeutics Files 10-K

Related Posts

Tenable’s Biggest Takeaway Is Doubling Its Unlevered FCF, Analyst Says

Citigroup Asked By SEC To Update Disclosures On Russia Exposure

Guggenheim Maintains Buy on Merus, Raises Price Target to $46

Tesla Giga Shanghai Said To Remain Shut Amid COVID-19 Lockdowns